Turku Bioscience funding news
The first semester is ending and summer holidays are approaching. Our researchers have worked hard to secure funding for their research projects, and several of them were rewarded for their hard work. Here is the list of the latest funding decisions.
Michael J Fox Foundation Target Advancement Program
- Eleanor Coffey as PI, 256,000$
Michael J Fox Foundation Parkinson’s pathway Molecular Data Analysis Program
- Eleanor Coffey as PI, 338,000$
Norwegian Research Council: Developing and Early Blood Test for Parkinson’s disease
- Eleanor Coffey as a partner, NOK 15M.
Business Finland
- Hongbo Zhang (Associate Professor), 667 191€
SynGap Research Fund
- Co-applicants Michael Courtney and Lili Li, 179 715€
Diabetes Research Foundation
- Robert Moulder, 27 000€
Finnish Cultural Foundation
- Lili Li, 40 000€
- Kedar Batkulwar, 30 000€
- Sami Ventelä, 40 500€
Previously announced Academy of Finland funding
Congratulations to all!
Recent Posts
- Meet our SAB over lunch!Turku Bioscience and BioCity Turku Scientific Advisory Board (SAB) is visiting Turku next week, and Read moreSeptember 16, 2026
- Dissertation Defence: Eleftheria MaranouMSc Eleftheria Maranou, from affiliated MIORG group, succesfully defended the dissertation in Immunology titled “The Achilles’ heel of Read moreSeptember 1, 2026
- Researchers discover molecular mechanism that helps aggressive colorectal cancer to spreadResearchers from the University of Turku in Finland, Turku Bioscience Centre and Gustave Roussy Institute Read moreAugust 25, 2026
- The Novo Nordisk Foundation has awarded funding of approximately one million euros to a research project led by Professor Jukka WestermarckThe Novo Nordisk Foundation has awarded funding of approximately one million euros to a research Read moreAugust 21, 2026
- The Jane and Aatos Erkko Foundation has granted nearly €1 million to support research led by Professor Jukka Westermarck993 000 € was granted to a research project led by our Group Leader Professor Jukka Read moreApril 2, 2026
- Cecilia Sahlgren’s group discovers a new mechanism driving breast cancer progressionOur affiliated research group led by Professor Cecilia Sahlgren at Åbo Akademi University and the InFLAMES Research Read moreMarch 25, 2026